BACKGROUND Gastrointestinal(GI)hemangioma has a low incidence among systemic hemangiomas,and some GI hemangiomas occur in the intestine,stomach,and esophagus.Polidocanol has been increasingly used in sclerotherapy.How...BACKGROUND Gastrointestinal(GI)hemangioma has a low incidence among systemic hemangiomas,and some GI hemangiomas occur in the intestine,stomach,and esophagus.Polidocanol has been increasingly used in sclerotherapy.However,this paper reports that minimally invasive treatment of multiple hemangiomas with large diameters can achieve satisfactory results by multipoint injection.CASE SUMMARY A 46-year-old female patient was hospitalized in another hospital for cough.We accidentally found thickening of the lower esophagus by chest computed tomography.The patient was eventually diagnosed with multiple GI hemangiomas and underwent a series of examinations including esophagogastroduodenoscopy(EGD),endoscopic ultrasound,and magnetic resonance imaging.We calculated the dose of polidocanol according to the volumes of the hemangiomas,fixed the target vein with the help of a transparent cap,and then administered polidocanol via multipoint injection into the hemangiomas under endoscopic guidance.EGD and endoscopic ultrasound showed that the hemangiomas disappeared.The color of the esophageal mucosa returned to normal 1 mo after sclerotherapy.CONCLUSION Sclerotherapy may be a safe and effective method for treating multiple hemangiomas of the alimentary canal.展开更多
Polidocanol is the most widely used Sclerotherapy in European and American countries. It is affordable, easy to use and apply, and has high efficiency. The purpose of this paper is to give an overview of the recent ba...Polidocanol is the most widely used Sclerotherapy in European and American countries. It is affordable, easy to use and apply, and has high efficiency. The purpose of this paper is to give an overview of the recent basics of the Sclerotherapy, chemistry and formulation, clinical applications, and side-effects and complications of Polidocanol, and to discuss the Polidocanol as the safety and efficacy of Sclerotherapy.展开更多
BACKGROUND Aneurysmal bone cysts(ABC)are benign cystic bone tumors of an osteolytic and locally aggressive nature.As an alternative to the primary treatment of choice,which consists of curettage with bone grafting,alt...BACKGROUND Aneurysmal bone cysts(ABC)are benign cystic bone tumors of an osteolytic and locally aggressive nature.As an alternative to the primary treatment of choice,which consists of curettage with bone grafting,alternative treatment methods with promising results have been described.At our department,we have,in recent years,used percutaneous sclerotherapy with polidocanol.The objective of this study was to identify the healing rate and safety of sclerotherapy with polidocanol.AIM To identify the efficacy and safety of sclerotherapy with polidocanol in primary and recurrent ABC.METHODS Twenty-two consecutive patients(median age 12.5 years;range 1-27)with 23 ABCs treated with sclerotherapy with polidocanol from 2016-2021 were included retrospectively.Eleven patients(48%)had undergone different forms of previous treatment with recurrence.Under general anesthesia and fluoroscopic guidance,repeated percutaneous injections of 4mg polidocanol/kg body weight were performed.Through review of the electronic medical records,the following were identified:healing and recurrence rate,number of treatments,gender,age,comorbidity,location of the tumor and side effects/complications,as well as any previous surgery for ABC.The median length of radiographic follow-up was 19.5 mo.RESULTS All ABCs except one(96%)showed healing or stable disease after a median of 4(range 1-8)injections.Complete clinical and radiographic healing was observed in 16 cysts(70%),while partial radiographic healing with resolution of pain was seen in 6 cases(26%)and considered as stable disease.The cyst that failed to heal had previously undergone curettage twice with recurrence.One patient with a large pelvic ABC experienced,right after two injections,a sudden drop in blood pressure,which could quickly be reversed.One patient with a juxtaphyseal ABC in the femoral neck showed a minor limb length discrepancy because of deformity.Beyond that,no complications were observed.CONCLUSION Percutaneous sclerotherapy with polidocanol appears to be a safe alternative for treatment of aneurysmal bone cysts.In our series of both primary and recurrent cysts,it showed the ability to achieve healing or stable disease in 22 of 23 cases(96%).Further studies are needed to decide if this provides a long-lasting effect.展开更多
目的观察腔内激光闭合联合聚多卡醇泡沫硬化剂及地奥司明术后巩固治疗下肢静脉曲张的疗效,并探讨其对瘤坏死因子-α(TNF-α)、白介素-6(IL-6)的影响。方法选取2014年3月至2015年3月广州医科大学第一附属医院整形外科收治的60例下肢静脉...目的观察腔内激光闭合联合聚多卡醇泡沫硬化剂及地奥司明术后巩固治疗下肢静脉曲张的疗效,并探讨其对瘤坏死因子-α(TNF-α)、白介素-6(IL-6)的影响。方法选取2014年3月至2015年3月广州医科大学第一附属医院整形外科收治的60例下肢静脉曲张患者,按照随机数字表法将其分为对照组和观察组,每组30例。对照组采用对大隐静脉行高位结扎术以及剥脱术,术后进行加压巩固治疗。观察组采用腔内激光闭合及泡沫硬化剂聚多卡醇注射,术后加压并予口服地奥司明辅助巩固治疗。观察两组患者的手术时间、手术出血量、术后住院时间及术后并发症;采用静脉疾病临床分类系统(CEAP)、静脉临床严重程度评分(VCSS)评价两组疗效;比较两组患者治疗前后的TNF-α、IL-6水平。结果两组患者术后1个月CEAP临床分级均较治疗前下降,差异有统计学意义(P<0.05);术后随访6个月,对照组患者的CEAP临床分级较术后上升发生率为26.67%(8/30),明显多于观察组6.67%(3/30),差异有统计学意义(P<0.05);观察组患者术后6个月VCSS评分为(1.89±0.65),明显低于对照组的(3.12±0.83),差异有显著统计学意义(P<0.01);观察组患者术后6个月血清TNF-α、IL-6浓度差值较术前明显减少[TNF-α(16.86±3.91)pg/m L vs(7.34±4.99)pg/m L;IL-6(31.96±9.78)pg/m L vs(5.81±4.11)pg/m L],差异均有显著统计学意义(P<0.01)。结论腔内激光闭合联合泡沫硬化剂聚多卡醇及地奥司明术后巩固治疗能够明显减少CEAP临床分级与VCSS评分,短期疗效与常规手术治疗相当。同时,其能够明显减少术后复发率,远期疗效显著,可能与抑制TNF-α、减少IL-6生成相关。展开更多
文摘BACKGROUND Gastrointestinal(GI)hemangioma has a low incidence among systemic hemangiomas,and some GI hemangiomas occur in the intestine,stomach,and esophagus.Polidocanol has been increasingly used in sclerotherapy.However,this paper reports that minimally invasive treatment of multiple hemangiomas with large diameters can achieve satisfactory results by multipoint injection.CASE SUMMARY A 46-year-old female patient was hospitalized in another hospital for cough.We accidentally found thickening of the lower esophagus by chest computed tomography.The patient was eventually diagnosed with multiple GI hemangiomas and underwent a series of examinations including esophagogastroduodenoscopy(EGD),endoscopic ultrasound,and magnetic resonance imaging.We calculated the dose of polidocanol according to the volumes of the hemangiomas,fixed the target vein with the help of a transparent cap,and then administered polidocanol via multipoint injection into the hemangiomas under endoscopic guidance.EGD and endoscopic ultrasound showed that the hemangiomas disappeared.The color of the esophageal mucosa returned to normal 1 mo after sclerotherapy.CONCLUSION Sclerotherapy may be a safe and effective method for treating multiple hemangiomas of the alimentary canal.
文摘Polidocanol is the most widely used Sclerotherapy in European and American countries. It is affordable, easy to use and apply, and has high efficiency. The purpose of this paper is to give an overview of the recent basics of the Sclerotherapy, chemistry and formulation, clinical applications, and side-effects and complications of Polidocanol, and to discuss the Polidocanol as the safety and efficacy of Sclerotherapy.
文摘BACKGROUND Aneurysmal bone cysts(ABC)are benign cystic bone tumors of an osteolytic and locally aggressive nature.As an alternative to the primary treatment of choice,which consists of curettage with bone grafting,alternative treatment methods with promising results have been described.At our department,we have,in recent years,used percutaneous sclerotherapy with polidocanol.The objective of this study was to identify the healing rate and safety of sclerotherapy with polidocanol.AIM To identify the efficacy and safety of sclerotherapy with polidocanol in primary and recurrent ABC.METHODS Twenty-two consecutive patients(median age 12.5 years;range 1-27)with 23 ABCs treated with sclerotherapy with polidocanol from 2016-2021 were included retrospectively.Eleven patients(48%)had undergone different forms of previous treatment with recurrence.Under general anesthesia and fluoroscopic guidance,repeated percutaneous injections of 4mg polidocanol/kg body weight were performed.Through review of the electronic medical records,the following were identified:healing and recurrence rate,number of treatments,gender,age,comorbidity,location of the tumor and side effects/complications,as well as any previous surgery for ABC.The median length of radiographic follow-up was 19.5 mo.RESULTS All ABCs except one(96%)showed healing or stable disease after a median of 4(range 1-8)injections.Complete clinical and radiographic healing was observed in 16 cysts(70%),while partial radiographic healing with resolution of pain was seen in 6 cases(26%)and considered as stable disease.The cyst that failed to heal had previously undergone curettage twice with recurrence.One patient with a large pelvic ABC experienced,right after two injections,a sudden drop in blood pressure,which could quickly be reversed.One patient with a juxtaphyseal ABC in the femoral neck showed a minor limb length discrepancy because of deformity.Beyond that,no complications were observed.CONCLUSION Percutaneous sclerotherapy with polidocanol appears to be a safe alternative for treatment of aneurysmal bone cysts.In our series of both primary and recurrent cysts,it showed the ability to achieve healing or stable disease in 22 of 23 cases(96%).Further studies are needed to decide if this provides a long-lasting effect.
文摘目的观察腔内激光闭合联合聚多卡醇泡沫硬化剂及地奥司明术后巩固治疗下肢静脉曲张的疗效,并探讨其对瘤坏死因子-α(TNF-α)、白介素-6(IL-6)的影响。方法选取2014年3月至2015年3月广州医科大学第一附属医院整形外科收治的60例下肢静脉曲张患者,按照随机数字表法将其分为对照组和观察组,每组30例。对照组采用对大隐静脉行高位结扎术以及剥脱术,术后进行加压巩固治疗。观察组采用腔内激光闭合及泡沫硬化剂聚多卡醇注射,术后加压并予口服地奥司明辅助巩固治疗。观察两组患者的手术时间、手术出血量、术后住院时间及术后并发症;采用静脉疾病临床分类系统(CEAP)、静脉临床严重程度评分(VCSS)评价两组疗效;比较两组患者治疗前后的TNF-α、IL-6水平。结果两组患者术后1个月CEAP临床分级均较治疗前下降,差异有统计学意义(P<0.05);术后随访6个月,对照组患者的CEAP临床分级较术后上升发生率为26.67%(8/30),明显多于观察组6.67%(3/30),差异有统计学意义(P<0.05);观察组患者术后6个月VCSS评分为(1.89±0.65),明显低于对照组的(3.12±0.83),差异有显著统计学意义(P<0.01);观察组患者术后6个月血清TNF-α、IL-6浓度差值较术前明显减少[TNF-α(16.86±3.91)pg/m L vs(7.34±4.99)pg/m L;IL-6(31.96±9.78)pg/m L vs(5.81±4.11)pg/m L],差异均有显著统计学意义(P<0.01)。结论腔内激光闭合联合泡沫硬化剂聚多卡醇及地奥司明术后巩固治疗能够明显减少CEAP临床分级与VCSS评分,短期疗效与常规手术治疗相当。同时,其能够明显减少术后复发率,远期疗效显著,可能与抑制TNF-α、减少IL-6生成相关。
